Package 43742-2036-1
Brand: vir combination
Generic: influenzinum (2020-2021), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosodePackage Facts
Identity
Package NDC
43742-2036-1
Digits Only
4374220361
Product NDC
43742-2036
Description
30 mL in 1 BOTTLE, DROPPER (43742-2036-1)
Marketing
Marketing Status
Brand
vir combination
Generic
influenzinum (2020-2021), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8df251cd-be49-44d3-b456-badf4ba1c4af", "openfda": {"unii": ["77H9EM77P7", "TM54L796SN", "FKD3DUK39I", "22G38P19RL", "74J6DNH49U", "2A26YW7PNX", "7COI029E6K", "4IX4VP35CR", "NY1FF92M1E", "P8ORN3UOM6", "B93BQX9789", "VEH9U90EHX"], "spl_set_id": ["d48d741e-c6b2-45bd-a102-9b793f62a53c"], "manufacturer_name": ["Deseret Biologicals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE, DROPPER (43742-2036-1)", "package_ndc": "43742-2036-1", "marketing_end_date": "20261001", "marketing_start_date": "20210909"}], "brand_name": "Vir Combination", "product_id": "43742-2036_8df251cd-be49-44d3-b456-badf4ba1c4af", "dosage_form": "LIQUID", "pharm_class": ["Actively Acquired Immunity [PE]", "Actively Acquired Immunity [PE]", "Live Human Adenovirus Type 4 Vaccine [EPC]", "Live Human Adenovirus Type 7 Vaccine [EPC]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]"], "product_ndc": "43742-2036", "generic_name": "Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode", "labeler_name": "Deseret Biologicals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vir Combination", "active_ingredients": [{"name": "HEPATITIS B VIRUS", "strength": "33 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN", "strength": "12 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN", "strength": "12 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 1", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 2", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 4", "strength": "16 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 5", "strength": "18 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 6", "strength": "15 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_end_date": "20261001", "marketing_start_date": "20210909"}